GENEVA, Switzerland – March 15, 2023 – ObsEva SA (OBSV) (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results